StageZero Life Sciences Ltd T.SZLS

Why not SZLS?

[7s5911]

Exact Sciences — Shares added 6% on news of research agreements with The MIT and Harvard Broad Institute to exclusively use the company’s molecular residual disease diagnostic testing platform.

[LithLover]

Exactly why doesn't the CEO, the board of directors or scientific board have these relationships.   Can't anyone associated with Stage sell or market this company.  

[molotov420]

makes ya wonder what is really going on behind the curtain. Is it just tripp looking up cancer statistic in an empty office so he can update his slides for next quarters presentation? Rebecca told me in 2021 that they were selling tests yet they cant show any revenue....what gives?

[LithLover]

They have access to $25 Million.  $25 million is unheard of for such a small company.  Use that to: -market (radio, TV, social media, sponsorships, SEO, Google ads) -give away free tests by using the cash to cover cost of goods, -or drop the price of tests to $500 for the first year until you gain traction -hire dozens of sales people, -hire a marketing company, -hire a VP Sales, -hire

[IainCaimbeul]

LL, send this email to Stage and apply for the job of Senior VP Sales, good luck.

[LithLover]

LOL.  Thanks but I started my own company and have grown it past what Stage gets in revenues.   I used cold calling, radio, post cards, SEO, Social media, free service/products for new customers, Google adwords (we are top 3 in our area for searches) etc.  My advertising/marketing was well over 35% of my admin costs for the first few years but it grew the company. You either

[Liked2Think]

It's already sucked for a few years after they blew all the cash they made on the gift that was Covid to them.  they have not done one bit of marketing. Not one bit! spend a grand a month doing Facebook ads that is nothing but no they do absolutely nothing.  morons leading morons in this company.  Matt knew this right away likely tried to change things. Was told that

[LithLover]

Can't argure that.  And we all know the definition of insanity.   Time to open the war chest and see if the test has legs by doing everything they can to market and sell it.  Tripp has to decide if he has it in him to change focus and move the company forward or pass the torch and get people in place who can.  The last 2 years was a bust from a revenue point of view

[IainCaimbeul]

Couple of years ago in an interview with Tripp an analyst (minerals guy) stated that Aristotle ..."would sell itself...". Obviously Tripp believed that rubbish and has not changed course since. If we where selling even modest numbers of Aristotle tests we should be shouting from the roof tops, but NO, crickets, Tripp is not a part of the solution, he is in fact a large of the problem

[telman]

The fact that GEM gave them that money just boggles the mind.  Like what made them do that?  Look at the history do they think owning the stock will actually pay off in the end?  If not why else would they give them access to that money. Its almost like each time Stage suckers someone else to give them money at a lower sp that company thinks its at the bottom so they can make a

[molotov420]

I think the Care revenue was accurate when they purchased. Tripp is just trying to sweep that under the rug now to make it look like they are actually making money.....show us 1.5M per quarter, or 2M. Then I will believe something is actually happening.  A 15% increase from the worste quarter ever is a joke and nothing to write home about.